These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35925737)

  • 41. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.
    Gomar JJ; Bobes-Bascaran MT; Conejero-Goldberg C; Davies P; Goldberg TE;
    Arch Gen Psychiatry; 2011 Sep; 68(9):961-9. PubMed ID: 21893661
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.
    Sabri O; Meyer PM; Gräf S; Hesse S; Wilke S; Becker GA; Rullmann M; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Tiepolt S; Fischer S; Deuther-Conrad W; Hegerl U; Barthel H; Schönknecht P; Brust P
    Brain; 2018 Jun; 141(6):1840-1854. PubMed ID: 29672680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy.
    Teylan M; Mock C; Gauthreaux K; Chen YC; Chan KCG; Hassenstab J; Besser LM; Kukull WA; Crary JF
    Brain; 2020 Feb; 143(2):611-621. PubMed ID: 31942622
    [TBL] [Abstract][Full Text] [Related]  

  • 44. How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer's disease?
    Benge JF; Balsis S; Geraci L; Massman PJ; Doody RS
    Dement Geriatr Cogn Disord; 2009; 28(1):63-9. PubMed ID: 19641319
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.
    Ayutyanont N; Langbaum JB; Hendrix SB; Chen K; Fleisher AS; Friesenhahn M; Ward M; Aguirre C; Acosta-Baena N; Madrigal L; Muñoz C; Tirado V; Moreno S; Tariot PN; Lopera F; Reiman EM
    J Clin Psychiatry; 2014 Jun; 75(6):652-60. PubMed ID: 24816373
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Picture-naming test for a linguistically diverse population with cognitive impairment and dementia.
    Paplikar A; Varghese F; Alladi S; Vandana VP; Darshini KJ; Iyer GK; Kandukuri R; Divyaraj G; Sharma M; Dhaliwal RS; Kaul S; Saroja AO; Ghosh A; Sunitha J; Khan AB; Mathew R; Mekala S; Menon R; Nandi R; Narayanan J; Nehra A; Padma MV; Pauranik A; Ramakrishnan S; Sarath L; Shah U; Tripathi M; Sylaja PN; Varma RP; Verma M; Vishwanath Y;
    Int J Lang Commun Disord; 2022 Jul; 57(4):881-894. PubMed ID: 35522006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.
    Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM
    Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparing patient and informant ratings of depressive symptoms in various stages of Alzheimer's disease.
    Gold D; Rosowsky E; Piryatinsky I; Sinclair SJ
    Neuropsychology; 2020 Jul; 34(5):535-550. PubMed ID: 32191055
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Executive and Language Subjective Cognitive Decline Complaints Discriminate Preclinical Alzheimer's Disease from Normal Aging.
    Valech N; Tort-Merino A; Coll-Padrós N; Olives J; León M; Rami L; Molinuevo JL
    J Alzheimers Dis; 2018; 61(2):689-703. PubMed ID: 29254090
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metrological properties of neuropsychological tests for measuring cognitive change in individuals with prodromal Alzheimer's disease.
    Zhang X; Wu Y; He Y; Ge X; Cui J; Han H; Luo Y; Liu L; Wang Z; Yu H;
    Aging Ment Health; 2022 Oct; 26(10):1988-1996. PubMed ID: 34409904
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Performance on neuropsychological assessment and progression to dementia: A meta-analysis.
    Prado CE; Watt S; Treeby MS; Crowe SF
    Psychol Aging; 2019 Nov; 34(7):954-977. PubMed ID: 31682146
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Item response theory facilitated cocalibrating cognitive tests and reduced bias in estimated rates of decline.
    Crane PK; Narasimhalu K; Gibbons LE; Mungas DM; Haneuse S; Larson EB; Kuller L; Hall K; van Belle G
    J Clin Epidemiol; 2008 Oct; 61(10):1018-27.e9. PubMed ID: 18455909
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and application of the International Classification of Cognitive Disorders in Epilepsy (IC-CoDE): Initial results from a multi-center study of adults with temporal lobe epilepsy.
    McDonald CR; Busch RM; Reyes A; Arrotta K; Barr W; Block C; Hessen E; Loring DW; Drane DL; Hamberger MJ; Wilson SJ; Baxendale S; Hermann BP
    Neuropsychology; 2023 Mar; 37(3):301-314. PubMed ID: 35084879
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer's disease.
    Marshall GA; Rentz DM; Frey MT; Locascio JJ; Johnson KA; Sperling RA;
    Alzheimers Dement; 2011 May; 7(3):300-8. PubMed ID: 21575871
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies.
    Rabin LA; Smart CM; Crane PK; Amariglio RE; Berman LM; Boada M; Buckley RF; Chételat G; Dubois B; Ellis KA; Gifford KA; Jefferson AL; Jessen F; Katz MJ; Lipton RB; Luck T; Maruff P; Mielke MM; Molinuevo JL; Naeem F; Perrotin A; Petersen RC; Rami L; Reisberg B; Rentz DM; Riedel-Heller SG; Risacher SL; Rodriguez O; Sachdev PS; Saykin AJ; Slavin MJ; Snitz BE; Sperling RA; Tandetnik C; van der Flier WM; Wagner M; Wolfsgruber S; Sikkes SA
    J Alzheimers Dis; 2015 Sep; 48 Suppl 1(0 1):S63-86. PubMed ID: 26402085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cognitive trajectories preluding the imminent onset of Alzheimer's disease dementia in individuals with normal cognition: results from the HELIAD cohort.
    Liampas I; Siokas V; Ntanasi E; Kosmidis MH; Yannakoulia M; Sakka P; Hadjigeorgiou GM; Scarmeas N; Dardiotis E
    Aging Clin Exp Res; 2023 Jan; 35(1):41-51. PubMed ID: 36322329
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An Abbreviated Montreal Cognitive Assessment (MoCA) for Dementia Screening.
    Horton DK; Hynan LS; Lacritz LH; Rossetti HC; Weiner MF; Cullum CM
    Clin Neuropsychol; 2015; 29(4):413-25. PubMed ID: 25978540
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Montreal Cognitive Assessment (MoCA) Performance and Domain-Specific Index Scores in Amnestic
    Wood JL; Weintraub S; Coventry C; Xu J; Zhang H; Rogalski E; Mesulam MM; Gefen T
    J Int Neuropsychol Soc; 2020 Oct; 26(9):927-931. PubMed ID: 32423505
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of exercise interventions for specific cognitive domains in old adults with mild cognitive impairment: A meta-analysis and subgroup analysis of randomized controlled trials.
    Zhou XL; Wang LN; Wang J; Zhou L; Shen XH
    Medicine (Baltimore); 2020 Jul; 99(31):e20105. PubMed ID: 32756073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.